Odyssey Therapeutics Ord Shs (Proposed)

Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.

Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.

Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.

In its most recent quarterly, Odyssey Therapeutics Ord Shs (Proposed) had 35.72M in cash and cash equivalents.

Odyssey Therapeutics Ord Shs (Proposed) reported 54.51M in total liabilities as of the latest reported quarter, including 26.48M in current liabilities and 28.03M in non-current liabilities.

As of the latest reported quarter, Odyssey Therapeutics Ord Shs (Proposed)'s total assets were 269.79M, consisting of 190.66M in current assets and 79.13M in non-current assets.

Odyssey Therapeutics Ord Shs (Proposed) reported 215.28M in total shareholders' equity as of the latest reported quarter.